Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 3546 entries
View as:

A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise

Phase: N/A Priority: Normal
NCT ID: NCT01435902 Org: User:
Start: 01/31/12 End: 08/31/12 Due: 08/31/13

Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults.

Phase: N/A Priority: Normal
NCT ID: NCT00714285 Org: User:
Start: 07/14/08 End: 01/28/09 Due: 01/28/10

Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population

Phase: N/A Priority: Normal
NCT ID: NCT00318058 Org: User:
Start: 10/03/05 End: 11/04/05 Due: 11/04/06

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT03439657 Org: User:
Start: 04/12/18 End: 03/03/20 Due: 03/03/21

Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients

Phase: N/A Priority: Normal
NCT ID: NCT02119156 Org: User:
Start: 05/13/14 End: 12/14/18 Due: 12/14/19

Coreg and HSRs-Updated Analysis

Phase: N/A Priority: Normal
NCT ID: NCT01316952 Org: User:
Start: 06/30/10 End: 03/31/11 Due: 03/31/12

First Time in Human Study With GSK1018921

Phase: N/A Priority: Normal
NCT ID: NCT00527020 Org: User:
Start: 08/10/07 End: 07/12/08 Due: 07/12/09

A Study of Safety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00849875 Org: User:
Start: 05/26/09 End: 11/17/14 Due: 11/17/15

Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM

Phase: N/A Priority: Normal
NCT ID: NCT00969436 Org: User:
Start: 11/09/09 End: 02/21/11 Due: 02/21/12

Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02570165 Org: User:
Start: 11/06/15 End: 07/06/16 Due: 07/06/17

A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2379 in Normal Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01018628 Org: User:
Start: 12/07/09 End: 08/06/10 Due: 08/06/11

HLA-B*5701 And Hypersensitivity To Abacavir

Phase: N/A Priority: Normal
NCT ID: NCT00373945 Org: User:
Start: 08/31/06 End: 08/31/07 Due: 08/31/08

Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT04484623 Org: User:
Start: 10/01/20 End: 10/25/29 Due: 10/25/30

Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00334282 Org: User:
Start: 04/30/06 End: 12/31/14 Due: 12/31/15

Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

Phase: N/A Priority: Normal
NCT ID: NCT00134732 Org: User:
Start: 07/31/05 End: 05/31/06 Due: 05/31/07

Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00306644 Org: User:
Start: 05/31/02 End: 11/30/04 Due: 11/30/05

Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00469378 Org: User:
Start: 07/31/07 End: 02/28/10 Due: 02/28/11

Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)

Phase: N/A Priority: Normal
NCT ID: NCT02730351 Org: User:
Start: 05/25/16 End: 02/03/17 Due: 02/03/18

A Safety, Tolerability, Pharmacokinetics (PK) and Target Engagement (TE) Study of GSK3858279 in Healthy Participants and Evaluation of the Efficacy of Repeat Doses in Participants With Osteoarthritis (OA)

Phase: N/A Priority: Normal
NCT ID: NCT03485365 Org: User:
Start: 05/17/18 End: 09/12/22 Due: 09/12/23

Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1

Phase: N/A Priority: Normal
NCT ID: NCT00678886 Org: User:
Start: 07/29/08 End: 01/31/12 Due: 01/31/13

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT01659086 Org: User:
Start: 08/22/12 End: 03/19/14 Due: 03/19/15

WEUSKOP5410: Observational Study in ENABLE Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT01458080 Org: User:
Start: 05/31/11 End: 11/30/13 Due: 11/30/14

GW572016 For Treatment Of Refractory Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00062686 Org: User:
Start: 11/30/03 End: 02/28/05 Due: 02/28/06

Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)

Phase: N/A Priority: Normal
NCT ID: NCT01332409 Org: User:
Start: 08/31/09 End: 01/31/13 Due: 01/31/14

Exploratory Study to Investigate Cognition Function and Mobility in Individuals With Pain

Phase: N/A Priority: Normal
NCT ID: NCT02974114 Org: User:
Start: 10/31/16 End: 02/06/17 Due: 02/06/18